Trial · NCT03703375
Adverse event totals24
The totals the trial posted for each group.
1 to 20 of 24
Download this page as JSON| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Oral Azacitidine: 200 mg | 6 | 8 |
| Total, all-cause mortality | Oral Azacitidine: 300 mg | 20 | 34 |
| Total, all-cause mortality | Investigators Choice Therapy - Romidepsin | 1 | 4 |
| Total, all-cause mortality | Investigators Choice Therapy - Bendamustine | 13 | 16 |
| Total, all-cause mortality | Investigators Choice Therapy - Gemcitabine: 1000 mg/m2 | 3 | 3 |
| Total, all-cause mortality | Investigators Choice Therapy - Gemcitabine: 1200 mg/m2 | 14 | 21 |
| Total, all-cause mortality | Safety Run-in Oral Azacitidine: 100 mg | 1 | 4 |
| Total, all-cause mortality | Safety Run-in Oral Azacitidine: 200 mg | 2 | 3 |
| Total, other adverse events | Oral Azacitidine: 200 mg | 7 | 8 |
| Total, other adverse events | Oral Azacitidine: 300 mg | 33 | 34 |
| Total, other adverse events | Investigators Choice Therapy - Romidepsin | 4 | 4 |
| Total, other adverse events | Investigators Choice Therapy - Bendamustine | 16 | 16 |
| Total, other adverse events | Investigators Choice Therapy - Gemcitabine: 1000 mg/m2 | 3 | 3 |
| Total, other adverse events | Investigators Choice Therapy - Gemcitabine: 1200 mg/m2 | 19 | 20 |
| Total, other adverse events | Safety Run-in Oral Azacitidine: 100 mg | 3 | 3 |
| Total, other adverse events | Safety Run-in Oral Azacitidine: 200 mg | 3 | 3 |
| Total, serious adverse events | Oral Azacitidine: 200 mg | 2 | 8 |
| Total, serious adverse events | Oral Azacitidine: 300 mg | 9 | 34 |
| Total, serious adverse events | Investigators Choice Therapy - Romidepsin | 2 | 4 |
| Total, serious adverse events | Investigators Choice Therapy - Bendamustine | 8 | 16 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03703375/event-totals